Prostate gland edema after single-fraction high-dose rate brachytherapy before external beam radiation therapy

Brachytherapy

Volumn 9, Issue 3, 2010, Pages 208-212

  Cury, Fabio L ^a   Duclos, Marie ^a   Aprikian, Armen ^a   Patrocinio, Horacio ^a   Souhami, Luis ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Edema; High dose rate brachytherapy; Hypofractionation; Prostate cancer

Indexed keywords

ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; HIGH DOSE RATE BRACHYTHERAPY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE GLAND EDEMA; PROSTATE HYPERTROPHY;

BRACHYTHERAPY; DOSE FRACTIONATION; EDEMA; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 77954957034     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.09.003     Document Type: Article

References (25)

1. Dearnaley D.P., Hall E., Lawrence D., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 2005, 92:488-498.
2. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:67-74.
3. Sathya J.R., Davis I.R., Julian J.A., et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol 2005, 23:1192-1199.
4. Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial. JAMA 2005, 294:1233-1239.
5. Chin Y.S., Bullard J., Bryant L., et al. High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer. Clin Oncol (R Coll Radiol) 2006, 18:474-479.
6. Demanes D.J., Rodriguez R.R., Schour L., et al. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys 2005, 61:1306-1316.
7. Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 2002, 52:6-13.
8. Wang J.Z., Li X.A., Yu C.X., et al. The low alpha/beta ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us?. Int J Radiat Oncol Biol Phys 2003, 57:1101-1108.
9. Shigehara K., Mizokami A., Komatsu K., et al. Four year clinical statistics of iridium-192 high dose rate brachytherapy. Int J Urol 2006, 13:116-121.
10. Pinkawa M., Fischedick K., Treusacher P., et al. Dose-volume impact in high-dose-rate iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer-A phase II study. Radiother Oncol 2006, 78:41-46.
11. Deger S., Boehmer D., Roigas J., et al. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer. Eur Urol 2005, 47:441-448.
12. Yamada Y., Bhatia S., Zaider M., et al. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 2006, 5:157-164.
13. Akimoto T., Katoh H., Noda S.E., et al. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys 2005, 63:472-478.
14. Hsu I.C., Cabrera A.R., Weinberg V., et al. Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer. Brachytherapy 2005, 4:202-206.
15. Pellizzon A.C., Nadalin W., Salvajoli J.V., et al. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. Radiother Oncol 2003, 66:167-172.
16. Astrom L., Pedersen D., Mercke C., et al. Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer. Radiother Oncol 2005, 74:157-161.
17. Martinez A.A., Demanes D.J., Galalae R., et al. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime. Int J Radiat Oncol Biol Phys 2005, 62:1322-1331.
18. Martinez A.A., Pataki I., Edmundson G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys 2001, 49:61-69.
19. Villeneuve M., Leclerc G., Lessard E., et al. Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants. Med Phys 2008, 35:1970-1977.
20. Taussky D., Austen L., Toi A., et al. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion. Int J Radiat Oncol Biol Phys 2005, 62:974-980.
21. Yamada Y., Potters L., Zaider M., et al. Impact of intraoperative edema during transperineal permanent prostate brachytherapy on computer-optimized and preimplant planning techniques. Am J Clin Oncol 2003, 26:e130-e135.
22. Dogan N., Mohideen N., Glasgow G.P., et al. Effect of prostatic edema on CT-based postimplant dosimetry. Int J Radiat Oncol Biol Phys 2002, 53:483-489.
23. Kiffer J.D., Schumer W.A., Mantle C.A., et al. Impact of oedema on implant geometry and dosimetry for temporary high dose rate brachytherapy of the prostate. Australas Radiol 2003, 47:172-176.
24. Lukka H., Warde P., Pickles T., et al. Controversies in prostate cancer radiotherapy: Consensus development. Can J Urol 2001, 8:1314-1322.
25. Poli M.E., Parker W., Patrocinio H., et al. An assessment of PTV margin definitions for patients undergoing conformal 3D external beam radiation therapy for prostate cancer based on an analysis of 10,327 pretreatment daily ultrasound localizations. Int J Radiat Oncol Biol Phys 2007, 67:1430-1437.